Nuvalent, Inc. (NASDAQ: NUVL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $115.00 price target on the stock.
Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results
Nuvalent, Inc. (NASDAQ: NUVL) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $100.00 price target on the stock.
Nuvalent, Inc. (NASDAQ: NUVL) had its price target raised by analysts at JPMorgan Chase & Co. from $100.00 to $125.00. They now have an "overweight" rating on the stock.
Nuvalent Announces Closing of Upsized Public Offering of Common Stock